Genetic Engineering & Biotechnology News

DEC 2018

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: https://gen.epubxp.com/i/1052771

Contents of this Issue

Navigation

Page 26 of 57

For more information, visit our website (GENengnews.com), click on New Products, and search through our comprehensive new products database. New Products GENengnews.com | Genetic Engineering & Biotechnology News | DECEMBER 2018 | 25 People Agilent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 11 BioSpec. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 Drummond Scienti•c . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15 GEN/Advanced Cell Diagnostics webinar. . . . . . . . . . 27 GEN/RedShiftBio webinar . . . . . . . . . . . . . . . . . . . . . . . . 14 GEN/Solentim webinar . . . . . . . . . . . . . . . . . . . . . . . . . . . 19 Mirus Bio . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7 OriGene . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9 PendoTECH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17 PerkinElmer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 RayBiotech . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 Terumo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 13 WuXi Biologics . . . . . . . . . . . . . . . . . . . . . . . . . . . . Cover Tip Advertiser Index U.S. Postal Service Statement of Ownership, Management, and Circulation ACADIA PHARMACEUTICALS hired Robert Kaper, M.D., as svp, global head of medical a'airs, and Eliseo Salinas, M.D., M.Sc., as svp, CSO, and head of external innovation. NGM BIOPHARMACEUTICALS welcomed David J. Woodhouse, Ph.D., as CEO, and Aetna Wun Trombley, Ph.D., as president and COO. BENITEC BIOPHARMA hired Gregory R. Reyes, M.D., Ph.D., as senior scienti•c advisor. Scott Garland is the new president and CEO of PORTOLA PHARMACEUTICALS. GENOCEA BIOSCIENCES added Thomas Davis, M.D., as CMO. NEWMAB THERAPEUTICS welcomed Ignacio Melero, M.D., Ph.D., as scienti•c advisor. Stephan A. Grupp, M.D., Ph.D., joined the clinical advisory board of CELLECTIS. Dimitrios Iliopoulos, Ph.D., is the new CEO of KYNAN PHARMA. ARCTURUS THERAPEUTICS welcomed Suezanne Parker, Ph.D., as vp, translational medicine. James E. Dentzer is the new president and CEO of CURIS. Volker Herrmann, M.D., joined SQZ BIOTECH as president and COO. WUXI BIOLOGICS added David R. Liu, Ph.D., to its scienti•c advisory board. Joseph Grzymski, Ph.D., joined RENOWN HEALTH as CSO. SIRANOMICS welcomed Dmitry Samarsky, Ph.D., as CTO. ABSCI added Andrew J.S. Jones, D.Phil., to its scienti•c advisory board. Anne Whitaker became CEO of DANCE BIOPHARM HOLDINGS. Eric Converse is the new CEO of AMRA MEDICAL. Laurie Goodman, Ph.D., joined CLEARLIGHT DIAGNOSTICS as CEO. SECOND GENOME welcomed Karim Dabbagh, Ph.D., as CEO. REINVENT BIOLOGICS added David Drez, M.D., as CMO. UBIOME elected Joseph Jimenez to its board of directors. Jimemez has held positions of business lead- ership in several companies, including Novartis, Clorox, ConAgra, and H.J. Heinz. He is also on the boards of directors at Proctor & Gamble and General Motors. Pro•le Stanley Lewis, M.D., joined ANSUN BIOPHARMA as CMO. Dr. Lewis was the CMO at TaiMed Biologics. Prior to that, he was a medical director at Genentech. Pro•le KARUNA PHARMACEUTICALS appointed JeŽ Jonas, M.D., to its board of directors. Dr. Jonas is the CEO of Sage Therapeutics. Previously, he was svp, R&D, pharmaceu- ticals, at Shire. Earlier in his career, he was evp of ISIS Pharmaceuticals. Pro•le Send your People Announcements to people@GENengnews.com Classi•ed -INI "EAD "EATER 3ONI"EAST 4ISSUE 4EAROR -INI "EAD "EATER -INI "EAD "EATER Ê-,1*/, "IO 0ULVERIZER #RYO #UP "IO 6ORTEXER nää°È£Ç°ÎÎÈÎ /--1Ê-*,-, -ICRO -INCER 1. Publication Title: GENETIC ENGINEERING & BIOTECHNOLOGY NEWS. 2. Publication Number: 658-690x. 3. Filing Date: November 9, 2018. 4. Issue Frequency: Published semi-monthly except for July, August, and December. 5. Number of Issues Published Annually: 21. 6. Annual Subscription Price: U.S. - $2,081.00. 7. Complete Mailing Address of Known O›ce of Publication (Not Printer): GEN Publishing, Inc., 140 Huguenot Street, New Rochelle, NY 10801. Contact Person: Vince Yesenosky. Telephone: (914) 740-2294. 8. Complete Mailing Address of Headquarters or General Business O›ce of Publisher (Not Printer): GEN Publishing, Inc., 140 Huguenot Street, New Rochelle, NY 10801. 9. Full Names and Complete Mailing Addresses of Publisher, Editor, and Managing Editor: Publisher—GEN Publishing, Inc., 140 Huguenot Street, New Rochelle, NY 10801; Editor—John Sterling, GEN Publishing, Inc., 140 Huguenot Street, New Rochelle, NY 10801; Managing Editor—none, GEN Publishing, Inc., 140 Huguenot Street, New Rochelle, NY 10801. 10. Owner: GEN Publishing, Inc., 140 Huguenot Street, New Rochelle, NY 10801. 11. Known Bondholders, Mortgagees, and Other Security Holders Owning or Holding 1 Percent or More of Total Amount of Bonds, Mortgages, or Other Securities: GEN Publishing, Inc., 140 Huguenot Street, New Rochelle, NY 10801. 12. Tax Status: Has Not Changed During Preceding 12 months. 13. Publication Title: GENETIC ENGINEERING & BIOTECHNOLOGY NEWS. 14. Issue Date for Circulation Data Below: 9/1/18. 15. Extent and Nature of Circulation: A. Total Number of Copies (Net press run): Average No. Copies Each Issue During Preceding 12 Months—44,585; No. Copies of Single Issue Published Nearest to Filing Date—42,640. B. Legitimate Paid and/ or Requested Distribution: (1) Outside County Paid/Requested Mail Subscriptions Stated on PS Form 3541: Average No. Copies Each Issue During Preceding 12 Months—26,363; No. Copies of Single Issue Published Nearest to Filing Date—26,125. (2) In-County Paid/Requested Mail Subscriptions Stated on PS Form 3541: Average No. Copies Each Issue During Preceding 12 Months—None; No. Copies of Single Issue Published Nearest to Filing Date—None. (3) Sales Through Dealers and Carriers, Street Vendors, Counter Sales, and Other Paid or Requested Distribution Outside USPS®: Average No. Copies Each Issue During Preceding 12 Months—4,734; No. Copies of Single Issue Published Nearest to Filing Date—4,526. (4) Requested Copies Distributed by Other Mail Classes Through the USPS: Average No. Copies Each Issue During Preceding 12 Months—None; No. Copies of Single Issue Published Nearest to Filing Date—None. C. Total Paid and/or Requested Circulation: Average No. Copies Each Issue During Preceding 12 Months—31,097; No. Copies of Single Issue Published Nearest to Filing Date—30,651. D. Nonrequested Distribution (by Mail and Outside the Mail): (1) Outside County Nonrequested Copies Stated on PS Form 3541: Average No. Copies Each Issue During Preceding 12 Months—11,650; No. Copies of Single Issue Published Nearest to Filing Date—11,175. (2) In-County Nonrequested Copies as Stated on PS Form 3541: Average No. Copies Each Issue During Preceding 12 Months—None; No. Copies of Single Issue Published Nearest to Filing Date—None. (3) Nonrequested Copies Distributed Through the USPS by Other Classes of Mail: Average No. Copies Each Issue During Preceding 12 Months—None; No. Copies of Single Issue Published Nearest to Filing Date—None. (4) Nonrequested Copies Distributed Outside the Mail: Average No. Copies Each Issue During Preceding 12 Months—1,718; No. Copies of Single Issue Published Nearest to Filing Date—694. E. Total Nonrequested Distribution: Average No. Copies Each Issue During Preceding 12 Months—3,368; No. Copies of Single Issue Published Nearest to Filing Date—11,869. F. Total Distribution: Average No. Copies Each Issue During Preceding 12 Months—444,65; No. Copies of Single Issue Published Nearest to Filing Date—42,520 G. Copies Not Distributed: Average No. Copies Each Issue During Preceding 12 Months—120; No. Copies of Single Issue Published Nearest to Filing Date—120. H. Total: Average No. Copies Each Issue During Preceding 12 Months—44,585; No. Copies of Single Issue Published Nearest to Filing Date—42,640. I. Percent Paid and/or Requested Circulation: Average No. Copies Each Issue During Preceding 12 Months—69.9%; No. Copies of Single Issue Published Nearest to Filing Date—72.1%. 16. Electronic Copy Circulation: A. Requested and Paid Electronic Copies: Average No. Copies Each Issue During Previous 12 Months—22,237; No. Copies of Single Issue Published Nearest to Filing Date—23,125. B. Total Requested and Paid Print Copies and Requested/Paid Electronic Copies: Average No. Copies Each Issue During Previous 12 Months—53,334; No. Copies of Single Issue Published Nearest to Filing Date—53,776. C. Total Requested Copy Distribution and Requested/Paid Electronic Copies: Average No. Copies Each Issue During Published Previous 12 Months—66,702; No. Copies of Single Issue Nearest to Filing Date—65,645. D. Percent Paid and/or Requested Circulation (Both Print and Electronic Copies): Average No. Copies Each Issue During Previous 12 Months—80.0%; No. Copies of Single Issue Published Nearest to Filing Date—81.9%. I certify that 50% of all my distributed copies (electronic and print) are legitimate requests or paid copies. 17. Publication of Statement of Ownership for a Requester Publication is required and will be printed in the December 1, 2018 issue of this publication. 18. I certify that all information furnished on this form is true and complete. — Vince Yesenosky, Subscription Fulllment & Retention Manager

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - DEC 2018